D Tc 99m Dimercaptosuccinic Acid SPECT Versus Planar

• Conditions: Dimercaptosuccinic Acid SPECT and Planar

• Registration Number: NCT04091685
• Lead Sponsor: Assiut University

Brief Summary

Knowing what will DMSA spect add to the DMSA planar in detection in renal cortical defects

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-09
• Study Start: 2019-09
• Study First Submitted: 2019-09-13
• Study First Submitted QC: 2019-09-13
• Last Update Submitted: 2019-09-13
• Study First Posted: 2019-09-17
• Last Update Posted: 2019-09-17
• Primary Completion: 2020-09
• Study Completion: 2020-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• patient with history of peylo nephritis.

Exclusion Criteria

• pregnant women

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison between DMSA spect and planar imaging	Baseline	Analysis of DMSA spect and planar imaging to clarify early renal cortical defects

Secondary Outcome Measures

Name	Time	Method
Clarify added value of DMSA spect over planar	Baseline	Know if DMSA spect is necessary?